PharmaCorp Rx Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Public

  • Stock Symbol
  • PCRX

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $0.52
  • (As of Monday Closing)

PharmaCorp Rx General Information

Description

PharmaCorp Rx Inc foremerly Proton Capital Corp is a Capital Pool Company. The principal business of the company is to identify and evaluate assets or businesses with a view to potentially acquiring them or interest therein by completing a purchase transaction, by exercising an option, or by any concomitant transaction.

Contact Information

Formerly Known As
Proton Capital Corp.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3603 Selinger Crescent
  • Regina, Saskatchewan S4V 2H7
  • Canada
Primary Industry
Special Purpose Acquisition Company (SPAC)
Stock Exchange
TSX
Corporate Office
  • 3603 Selinger Crescent
  • Regina, Saskatchewan S4V 2H7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaCorp Rx Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.52 $0.52 $0.31 - $0.65 $59.4M 115M 68.6K -$0.02

PharmaCorp Rx Financials Summary

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 15,710
Revenue 215 0 0
EBITDA (888) (428) (432)
Net Income (823) (348) (397)
Total Assets 17,707 1,749 2,014
Total Debt 657 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PharmaCorp Rx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaCorp Rx‘s full profile, request access.

Request a free trial

PharmaCorp Rx Executive Team (4)

Name Title Board Seat
Grady Brown Chief Executive Officer & Board Member
Calvin LeRoux Board Member & President
Terri Tatchell Chief Financial Officer
Paul Dale Chief Operating Officer
To view PharmaCorp Rx’s complete executive team members history, request access »

PharmaCorp Rx Board Members (6)

Name Representing Role Since
Alan Simpson Self Chairman & Board Member 000 0000
Calvin LeRoux PharmaCorp Rx Board Member & President 000 0000
Glenn Fradette Self Board Member 000 0000
Grady Brown PharmaCorp Rx Chief Executive Officer & Board Member 000 0000
Grant Hladun Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

PharmaCorp Rx Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharmaCorp RX (Pharmacy in Western Canada, Canada) 22-Aug-2024 000000000 00.000 Buildings and Property 0000 0000
Saskatoon Family Pharmacy 06-Jun-2024 PIPE 000.00 Other Healthcare Services
To view PharmaCorp Rx’s complete investments history, request access »

PharmaCorp Rx Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
Saskatoon Family Pharmacy 06-Jun-2024 0000 000.00 Completed
  • 0000000000 0
To view PharmaCorp Rx’s complete exits history, request access »

PharmaCorp Rx FAQs

  • When was PharmaCorp Rx founded?

    PharmaCorp Rx was founded in 2021.

  • Who is the CEO of PharmaCorp Rx?

    Grady Brown is the CEO of PharmaCorp Rx.

  • Where is PharmaCorp Rx headquartered?

    PharmaCorp Rx is headquartered in Regina, Canada.

  • What industry is PharmaCorp Rx in?

    PharmaCorp Rx’s primary industry is Special Purpose Acquisition Company (SPAC).

  • Is PharmaCorp Rx a private or public company?

    PharmaCorp Rx is a Public company.

  • What is PharmaCorp Rx’s stock symbol?

    The ticker symbol for PharmaCorp Rx is PCRX.

  • What is the current stock price of PharmaCorp Rx?

    As of 16-Sep-2024 the stock price of PharmaCorp Rx is $0.52.

  • What is the current market cap of PharmaCorp Rx?

    The current market capitalization of PharmaCorp Rx is $59.4M.

  • What is PharmaCorp Rx’s current revenue?

    The trailing twelve month revenue for PharmaCorp Rx is $215K.

  • What is PharmaCorp Rx’s annual earnings per share (EPS)?

    PharmaCorp Rx’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »